Asterias Biotherapeutics, Inc. — Form D
Asterias Biotherapeutics, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-02-23. The offering totals $4.0M, of which $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2015-02-23
- Form: D
- Accession: 0001140361-15-008385
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $4.0M
- Date of first sale: 2015-02-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-234539
Issuer
- Name: Asterias Biotherapeutics, Inc.
- CIK: 0001572552
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 230 CONSTITUTION DRIVE, MENLO PARK, CA, 94025
- Phone: 650-433-2900
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Andrew T Arno | Director | Menlo Park, CA |
| Alfred D Kingsley | Director | Irvine, CA |
| PEDRO LICHTINGER | Director | PARAMUS, NJ |
| Robert W Peabody | Director | Menlo Park, CA |
| Natale T Ricciardi | Director | Menlo Park, CA |
| Judith T Segall | Director | Menlo Park, CA |
| Michael D West | Director | Menlo Park, CA |
| Jane S Lebkowski | Executive Officer | Menlo Park, CA |
| PEDRO LICHTINGER | Executive Officer | PARAMUS, NJ |
| Robert W Peabody | Executive Officer | Menlo Park, CA |
| Judith T Segall | Executive Officer | Menlo Park, CA |
| Katharine S Spink | Executive Officer | Menlo Park, CA |
| Michael D West | Executive Officer | Menlo Park, CA |
| RICHARD T LeBUHN | Director | NEW YORK, NY |
| JUDITH W SEGALL | Director | MENLO PARK, CA |
Other filings by this issuer (2)
More